ScienceDex / Researcher record
Lin, Yi
- Mayo Clinic (no department on record)
From the FY2015 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2015
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $192,485 | 1 | #31,515 |
| 2016 | $556,493 | 2 | #14,497 |
| 2017 | $1,056,230 | 3 | #6,466 |
| 2018 | $543,897 | 2 | #16,770 |
| 2019 | $709,388 | 2 | #13,087 |
| 2021 | $713,488 | 1 | #14,515 |
| 2022 | $485,760 | 1 | #23,638 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2015 · selected1 record
- FY20162 records
- FY20173 records
- FY20182 records
- FY20192 records
- FY20211 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2015 award records by amount
NIH award records listing Lin, Yi as a PI. Multi-PI records show the full award amount for context.
- 1K22CA193674-01K22Contact PILymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance$192.5Kaward amount
Award organization
Organizations that administered FY2015 awards listing Lin, Yi as a PI.
FY2015 award administered by Mayo Clinic (AZ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardMayo Clinic
- 2016$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #6466
- 2018$2M Cumulative Funding